Encompass Health Co. (NYSE:EHC) CEO Sells $3,745,151.52 in Stock

Encompass Health Co. (NYSE:EHC - Get Free Report) CEO Mark J. Tarr sold 44,976 shares of the company's stock in a transaction dated Tuesday, April 30th. The shares were sold at an average price of $83.27, for a total transaction of $3,745,151.52. Following the sale, the chief executive officer now owns 554,098 shares of the company's stock, valued at $46,139,740.46. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Encompass Health Stock Down 0.6 %

Shares of NYSE EHC traded down $0.54 during midday trading on Wednesday, hitting $82.84. The stock had a trading volume of 543,838 shares, compared to its average volume of 670,891. The company has a market cap of $8.30 billion, a P/E ratio of 22.39, a PEG ratio of 1.31 and a beta of 0.94. The company has a quick ratio of 1.28, a current ratio of 1.37 and a debt-to-equity ratio of 1.14. The business's 50 day moving average is $78.64 and its 200-day moving average is $71.25. Encompass Health Co. has a 52 week low of $57.55 and a 52 week high of $85.84.

Encompass Health (NYSE:EHC - Get Free Report) last issued its earnings results on Wednesday, April 24th. The company reported $1.12 EPS for the quarter, beating the consensus estimate of $0.93 by $0.19. The business had revenue of $1.32 billion for the quarter, compared to the consensus estimate of $1.27 billion. Encompass Health had a return on equity of 18.01% and a net margin of 7.60%. The company's revenue was up 13.4% compared to the same quarter last year. During the same period last year, the business posted $0.88 EPS. As a group, analysts predict that Encompass Health Co. will post 4.1 EPS for the current year.

Encompass Health Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, April 15th. Stockholders of record on Monday, April 1st were issued a dividend of $0.15 per share. The ex-dividend date of this dividend was Thursday, March 28th. This represents a $0.60 annualized dividend and a dividend yield of 0.72%. Encompass Health's payout ratio is 16.22%.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on EHC shares. Truist Financial increased their target price on shares of Encompass Health from $82.00 to $86.00 and gave the stock a "buy" rating in a report on Friday, February 9th. Raymond James reissued a "strong-buy" rating and issued a $95.00 price target (up from $85.00) on shares of Encompass Health in a research note on Friday, April 26th. Royal Bank of Canada reaffirmed an "outperform" rating and set a $83.00 price objective on shares of Encompass Health in a research report on Friday, February 9th. William Blair reissued an "outperform" rating on shares of Encompass Health in a research report on Wednesday, February 7th. Finally, Mizuho lifted their price target on Encompass Health from $93.00 to $95.00 and gave the company a "buy" rating in a research report on Thursday, April 25th. Eight equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the stock has an average rating of "Buy" and a consensus target price of $88.13.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Legacy Wealth Asset Management LLC boosted its position in Encompass Health by 1.5% in the first quarter. Legacy Wealth Asset Management LLC now owns 8,619 shares of the company's stock worth $712,000 after purchasing an additional 130 shares during the last quarter. Smith Group Asset Management LLC grew its position in Encompass Health by 1.2% during the first quarter. Smith Group Asset Management LLC now owns 12,070 shares of the company's stock valued at $997,000 after buying an additional 140 shares during the period. Benjamin Edwards Inc. raised its position in Encompass Health by 3.8% in the fourth quarter. Benjamin Edwards Inc. now owns 3,885 shares of the company's stock worth $259,000 after acquiring an additional 142 shares during the period. Horrell Capital Management Inc. boosted its stake in shares of Encompass Health by 0.5% during the 1st quarter. Horrell Capital Management Inc. now owns 29,371 shares of the company's stock worth $2,425,000 after acquiring an additional 147 shares during the last quarter. Finally, GAMMA Investing LLC grew its position in shares of Encompass Health by 31.9% during the 1st quarter. GAMMA Investing LLC now owns 616 shares of the company's stock valued at $51,000 after acquiring an additional 149 shares during the period. Institutional investors own 97.25% of the company's stock.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.